ResMed Inc (BSP:R1MD34)
R$ 371.16 0 (0%) Market Cap: 217.94 Bil Enterprise Value: 220.49 Bil PE Ratio: 33.02 PB Ratio: 7.04 GF Score: 85/100

Q2 2024 Resmed Inc Earnings Call Transcript

Jan 24, 2024 / 09:30PM GMT
Release Date Price: R$202
Operator

Hello, and welcome to the ResMed Second Quarter Fiscal Year 2024 Earnings Conference Call and Webcast. (Operator Instructions) As a reminder, this conference is being recorded.

It's now my pleasure to turn the call over to Chief Investor Relations Officer, Amy Wakeham. Please go ahead, Amy.

Amy Wakeham
ResMed Inc. - Chief IR Officer

Great. Thank you, Kevin. Hi, everyone, and welcome to ResMed's Second Quarter Earnings Call for fiscal year 2024. We are live webcasting this call, and the replay will be available on the Investor Relations section of our corporate website later today, along with a copy of the earnings press release and presentation. Both of these are now available. During today's call, we will discuss several non-GAAP measures that we believe provide useful information for investors. This information is not intended to be considered in isolation or as a substitute for the GAAP financial information. We encourage you to review the supporting schedules in today's earnings press release for a reconciliation of these non-GAAP measures to the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot